The firm posted 2 percent overall revenue growth as strength in Europe and the Americas was offset by softness in China and the rest of Asia.
Diagnostics' products, including its in-development point-of-care molecular diagnostics system, in Saudi Arabia and 18 other MENA countries.
The firm posted 2 percent overall revenue growth as strength in Europe and the Americas was offset by softness in China and the rest of Asia.
Last week, readers were most interested in a story about Hologic's plans to go private via an acquisition by two private equity firms.
The firm posted 2 percent overall revenue growth as strength in Europe and the Americas was offset by softness in China and the rest of Asia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback